ATYR (aTyr Pharma, Inc.) שווי פירמה כולל

This daily price chart for aTyr Pharma, Inc. (ATYR) reflects an Enterprise Value of -34.14. The business focuses on therapies for orphan lung pathologies, ensuring perpetual demand for its developments. However, international expansion is hindered by regulatory barriers and raw material supply issues. To mitigate risks, aTyr Pharma, Inc. (ATYR) is adapting its technologies to combat cancer, thereby diversifying its clinical pipeline.

aTyr Pharma, Inc. (ATYR) is developing unique immunological drugs whose value remains independent of market cycles. The EV metric combines market capitalization and net debt to determine the total cost of acquiring the business. Investors utilize this metric to assess the actual costs of asset acquisition. The current EV value reflects the potential of the flagship candidate in late-stage testing. This chart allows for the tracking of the company's fair value.